教員・教室員について
助教
名前 | 森 康雄(もり やすお) |
---|---|
卒業年 | 2001(平成13)年 |
学位取得年月 | 2009年 医学博士学位取得 |
専門領域 | 血液内科学、造血細胞移植、幹細胞学 |
資格 | 日本内科学会認定医・専門医、日本血液学会専門医・指導医・評議員 日本造血細胞移植学会・認定医・評議員 |
所属学会 | 日本内科学会、日本血液学会、日本造血細胞移植学会、日本輸血細胞治療学会 |
略歴
2001~2003年 |
九州大学病院、九州医療センター、亀田総合病院 |
---|---|
2004~2010年 |
九州大学病態修復内科学、遺伝子細胞療法部 |
2010~2013年 |
日本学術振興会 特別研究員 |
2011~2014年 |
スタンフォード大学幹細胞生物学・再生医療研究所 研究員 |
2014年4月 |
九州大学病院 遺伝子細胞療法部 臨床助教 |
2015年4月 |
九州大学病院 血液・腫瘍内科 助教 |
代表的業績
- Mori Y, et al. Distinctive expression of myelomonocytic markers and downregulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation. Eur J Haematol. 2007; 20: 3010-21
- Kikushige Y, et al. Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival. J Immunol. 180(11): 7358-67. 2008
- Yoshimoto G, et al. FLT3-ITD upregulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation. Blood 114(24):5034-43. 2009
- Mori Y, et al. Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor. J Exp Med. 206(1):183-93. 2009
- Mori Y, et al. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. Biol Blood Marrow Transplant. 16(11):1596-602. 2010
- Mori Y, et al. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma. Am J Hematol. 85(6):449-51. 2010
- Mori Y, et al. Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 18(3):458-65. 2012
- Kikushige Y, et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell. 20(2):246-59. 2011
- Mori Y, et al. Diagnostic value of serum procalcitonin and C-reactive protein for infections after allogeneic hematopoietic stem cell transplantation versus nontransplant setting. Intern Med. 50(19):2149-55. 2011
- Mori Y, et al. Validation of pretransplantation assessment of mortality risk score in the outcome of hematopoietic SCT in non-Caucasians. Bone Marrow Transplant. 47(8):1075-81. 2012
- Miyanishi M*, Mori Y*, et al. (equally contributed) Do pluripotent stem cells exist in adult mice as very small embryonic stem cells? Stem Cell Reports. 1(2):198-208. 2013
- Ho CC et al. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.
J Biol Chem. 2015 May 15;290(20):12650-63. - Mori Y et al. Prospective isolation of human erythroid lineage-committed progenitors.
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9638-43. - Yoshimoto G, , et al.Human Herpes Virus-6-Associated Encephalitis/Myelitis Mimicking Calcineurin Inhibitor-Induced Pain Syndrome in Allogeneic Stem Cell Transplantation Recipients.
Biol Blood Marrow Transplant. 2018 Dec;24(12):2540-2548. - Mori Y, , et al.Gastrointestinal Graft-versus-Host Disease Is a Risk Factor for Postengraftment Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Biol Blood Marrow Transplant. 2018 Nov;24(11):2302-2309. - Mori Y*, et al.Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation.
Leuk Lymphoma. 2019 Jan;60(1):271-273. - Zhu F, et al.Screening for genes that regulate the differentiation of human megakaryocytic lineage cells.
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9308-E9316. - Miyawaki K, et al.Identification of unipotent megakaryocyte progenitors in human hematopoiesis.
Blood. 2017 Jun 22;129(25):3332-3343. - Mori Y, et al.Ruxolitinib treatment for GvHD in patients with myelofibrosis.
Bone Marrow Transplant. 2016 Dec;51(12):1584-1587.